Figure 7From: Clinical and pathologic factors associated with survival in young adult patients with fibrolamellar hepatocarcinomaSurvival analysis of prognostic factors of patients with FLC. Patients with (n = 9, median survival of 5 ± 2 months) and without (n = 6, median survival of 60 ± 10 months) vascular invasion, p = 0.006.Back to article page